These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15980112)
21. Treatment of ventilation-induced lung injury with exogenous surfactant. Vazquez de Anda GF; Lachmann RA; Gommers D; Verbrugge SJ; Haitsma J; Lachmann B Intensive Care Med; 2001 Mar; 27(3):559-65. PubMed ID: 11355126 [TBL] [Abstract][Full Text] [Related]
22. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome. Teksam O; Kale G Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732 [TBL] [Abstract][Full Text] [Related]
23. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus. Durward A; Forte V; Shemie SD Crit Care Med; 2000 Feb; 28(2):560-2. PubMed ID: 10708200 [TBL] [Abstract][Full Text] [Related]
24. Soluble TREM-1 and the diagnosis of pneumonia. Georges H; Leroy O; Guery B N Engl J Med; 2004 Apr; 350(18):1904-5; author reply 1904-5. PubMed ID: 15115838 [No Abstract] [Full Text] [Related]
25. Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice. Yang S; Milla C; Panoskaltsis-Mortari A; Ingbar DH; Blazar BR; Haddad IY Am J Respir Cell Mol Biol; 2001 May; 24(5):527-36. PubMed ID: 11350821 [TBL] [Abstract][Full Text] [Related]
26. Successful use of surfactant to treat severe intrapulmonary hemorrhage after iatrogenic lung injury--A case report. Haas NA; Kulasekaran K; Camphausen CK Pediatr Crit Care Med; 2006 Nov; 7(6):583-5. PubMed ID: 17006383 [TBL] [Abstract][Full Text] [Related]
27. Comparative effects of bronchoalveolar lavage with saline, surfactant, or perfluorocarbon in experimental meconium aspiration syndrome. Rey-Santano C; Mielgo VE; Gastiasoro E; Alvarez-Diaz FJ; Lafuente H; Valls-i-Soler A; Murgia X Pediatr Crit Care Med; 2012 May; 13(3):e187-94. PubMed ID: 22079955 [TBL] [Abstract][Full Text] [Related]
28. Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. Alberti A; Luisetti M; Braschi A; Rodi G; Iotti G; Sella D; Poletti V; Benori V; Baritussio A Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):817-20. PubMed ID: 8810625 [TBL] [Abstract][Full Text] [Related]
29. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Froese AB; McCulloch PR; Sugiura M; Vaclavik S; Possmayer F; Moller F Am Rev Respir Dis; 1993 Sep; 148(3):569-77. PubMed ID: 8368625 [TBL] [Abstract][Full Text] [Related]
30. High concentrations of GRO-alpha and MCP-1 in bronchoalveolar fluid of infants with respiratory distress syndrome after surfactant. Inwald DP; Costeloe K; Murch SH Arch Dis Child Fetal Neonatal Ed; 1998 May; 78(3):F234-5. PubMed ID: 9713044 [No Abstract] [Full Text] [Related]
31. Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease. Dargaville PA; South M; McDougall PN Am J Respir Crit Care Med; 1999 Sep; 160(3):771-7. PubMed ID: 10471595 [TBL] [Abstract][Full Text] [Related]
32. Allergic bronchopulmonary aspergillosis: a reversible cause of complete lung collapse. Braude S; Bowen D Intern Med J; 2011 Oct; 41(10):754-5. PubMed ID: 22435902 [No Abstract] [Full Text] [Related]
33. Surfactant replacement for ventilator-associated pneumonia: a preliminary report. Baughman RP; Henderson RF; Whitsett J; Gunther KL; Keeton DA; Waide JJ; Zaccardelli DS; Pattishall EN; Rashkin MC Respiration; 2002; 69(1):57-62. PubMed ID: 11844964 [TBL] [Abstract][Full Text] [Related]
34. Bronchoscopic treatment of pediatric atelectasis: A modified segmental insufflation-surfactant instillation technique. Šapina M; Olujic B; Nađ T; Vinkovic H; Dupan ZK; Bartulovic I; Milas K; Kos M; Divkovic D; Zubčić Ž; Erić I Pediatr Pulmonol; 2024 Mar; 59(3):625-631. PubMed ID: 38018688 [TBL] [Abstract][Full Text] [Related]
35. Effect of kinetic therapy on pulmonary complications. Ahrens T; Kollef M; Stewart J; Shannon W Am J Crit Care; 2004 Sep; 13(5):376-83. PubMed ID: 15470853 [TBL] [Abstract][Full Text] [Related]
36. Surfactant protein-A in bronchoalveolar lavage fluid from neonates with RDS on conventional and high-frequency oscillatory ventilation. Gerdes JS; Abbasi S; Karp K; Hull W; Whitsett JA Pediatr Pulmonol; 1990; 9(3):166-9. PubMed ID: 2277737 [TBL] [Abstract][Full Text] [Related]
37. Prospective evaluation of surfactant composition in bronchoalveolar lavage fluid of infants with congenital diaphragmatic hernia and of age-matched controls. IJsselstijn H; Zimmermann LJ; Bunt JE; de Jongste JC; Tibboel D Crit Care Med; 1998 Mar; 26(3):573-80. PubMed ID: 9504589 [TBL] [Abstract][Full Text] [Related]
38. Abnormal surfactant composition and activity in severe bronchiolitis. Skelton R; Holland P; Darowski M; Chetcuti PA; Morgan LW; Harwood JL Acta Paediatr; 1999 Sep; 88(9):942-6. PubMed ID: 10519333 [TBL] [Abstract][Full Text] [Related]
39. [Relation between citicoline and pulmonary surfactant. Recent acquisitions in the treatment of respiratory syndromes of the newborn]. Colombo ML; Dogliani P; Raggi M Minerva Pediatr; 1976 Nov; 28(37):2303-10. PubMed ID: 1036757 [No Abstract] [Full Text] [Related]
40. An infrequent cause of pulmonary atelectasis during mechanical ventilation. Casanueva J; Gilsanz FJ; Hernando P; Navarro E; Avello F Br J Anaesth; 1981 Mar; 53(3):319. PubMed ID: 7470367 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]